scispace - formally typeset
Open AccessJournal ArticleDOI

Simple and efficient CRISPR/Cas9-mediated targeted mutagenesis in Xenopus tropicalis.

TLDR
A standardized protocol for genome editing using the recently developed CRISPR/Cas system provides a powerful new reverse genetics tool for Xenopus researchers.
Abstract
We have assessed the efficacy of the recently developed CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated) system for genome modification in the amphibian Xenopus tropicalis. As a model experiment, targeted mutations of the tyrosinase gene were verified, showing the expected albinism phenotype in injected embryos. We further tested this technology by interrupting the six3 gene, which is required for proper eye and brain formation. Expected eye and brain phenotypes were observed when inducing mutations in the six3 coding regions, as well as when deleting the gene promoter by dual targeting. We describe here a standardized protocol for genome editing using this system. This simple and fast method to edit the genome provides a powerful new reverse genetics tool for Xenopus researchers.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

The new frontier of genome engineering with CRISPR-Cas9

TL;DR: The power of the CRISPR-Cas9 technology to systematically analyze gene functions in mammalian cells, study genomic rearrangements and the progression of cancers or other diseases, and potentially correct genetic mutations responsible for inherited disorders is illustrated.
Journal ArticleDOI

CRISPR-Cas systems for editing, regulating and targeting genomes

TL;DR: A modified version of the CRISPR-Cas9 system has been developed to recruit heterologous domains that can regulate endogenous gene expression or label specific genomic loci in living cells, which will undoubtedly transform biological research and spur the development of novel molecular therapeutics for human disease.
Journal ArticleDOI

CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing

TL;DR: An online tool, CHOPCHOP, that uses efficient sequence alignment algorithms to minimize search times, and rigorously predicts off-target binding of single-guide RNAs (sgRNAs) and TALENs, making it a valuable tool for genome engineering.
Journal ArticleDOI

CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes.

TL;DR: Recent developments that extend the generality, DNA specificity, product selectivity, and fundamental capabilities of natural CRISPR systems are described.
Journal ArticleDOI

Genome Engineering with Targetable Nucleases

TL;DR: Three classes of targetable cleavage reagents are described: zinc-finger nucleases, transcription activator-like effector nucleases (TALENs), and CRISPR/Cas RNA-guided nuclease (RGNs), which have been successfully used to modify genomic sequences in a wide variety of cells and organisms, including humans.
References
More filters
Journal ArticleDOI

Normal Table of Xenopus Laevis (Daudin)

Pieter D. Nieuwkoop, +1 more
- 21 Feb 1958 - 
Journal ArticleDOI

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.

TL;DR: The CRISPR/Cas system allows the one-step generation of animals carrying mutations in multiple genes, an approach that will greatly accelerate the in vivo study of functionally redundant genes and of epistatic gene interactions.
Journal ArticleDOI

Efficient genome editing in zebrafish using a CRISPR-Cas system

TL;DR: It is shown that the CRISPR-Cas system functions in vivo to induce targeted genetic modifications in zebrafish embryos with efficiencies similar to those obtained using zinc finger nucleases and transcription activator-like effector nucleases.
Journal ArticleDOI

Normal table of Xenopus laevis (Daudin)

J.B. Gurdon
- 01 Oct 1995 - 
Journal ArticleDOI

TALENs: a widely applicable technology for targeted genome editing

TL;DR: The newly-developed transcription activator-like effector nucleases (TALENs) comprise a nonspecific DNA-cleaving nuclease fused to a DNA-binding domain that can be easily engineered so that TALens can target essentially any sequence.
Related Papers (5)